On Monday 5th November, CRT will be hosting a workshop at the NCRI in Liverpool. The workshop is themed around cell based screening in cancer drug discovery and will feature speakers from both academia and industry.
The agenda for the workshop is as follow:
09:30-09:40 Introduction (Dr David Jenkinson, Portfolio Development Executive, Cancer Research Technology ltd)
09:40-10:10 Cell based Phenotypic Profiling: Advancing Preclinical Discovery Towards Improved Clinical Efficacy (Dr Neil Carragher, Principal Investigator Drug Discovery, Edinburgh Cancer Discovery Unit)
10:10-10:40 Exploiting Cell Based Screens to Interrogate Dysfunctional Pathways for Novel Cancer Therapeutics (Dr Jon Roffey, Group Leader, Medicinal Chemistry, Cancer Research Technology Ltd)
10:40-11:15 Refreshments and Networking
11:15-11:45 Back to the Future: Phenotypic Screening (Dr Christian Parker, High Throughput Biology, NIBR, Novartis Pharma AG)
11:45-12:15 Panel Session (Including speakers and Professor Herbie Newell, Professor of Cancer Therapeutics, Northern Institute of Cancer Research, Newcastle)
12:15-12:30 Close (Dr David Jenkinson)
The workshop takes place in Room 4 at the BT Convention Centre in Liverpool - please contact David Jenkinson (email@example.com) if you are interested in attending.